Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.95
1.58%
After-hours: Aug 15, 2025, 07:26 PM EDT
Chemomab Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 26.9K | n/a | 16.17K | 18.94K | 15.82K | 9.05M | 13.96K | 8.32M | 6.25M | 13.03K | 11.05K | 9.04K | 7.03K | 6.93K |
Gross Profit | n/a | n/a | n/a | -26.9K | n/a | -16.17K | -18.94K | -15.82K | -9.05M | -13.96K | -8.32M | -6.25M | -13.03K | -11.05K | -9.04K | -7.03K | -6.93K |
Operating Income | -3.49M | -3.21M | -3.71M | -3.77M | -4.09M | -3.89M | -4.37M | -8.2M | -9.06M | -8.64M | -8.32M | -6.25M | -5.32M | -5.02M | -2.89M | -2.75M | -1.7M |
Interest Income | n/a | 251.99K | n/a | 136.5K | 182K | 435.67K | 230.25K | 256.06K | 314.03K | 378.99K | 235.1K | n/a | 216.47K | n/a | n/a | n/a | n/a |
Pretax Income | -3.32M | -2.96M | -3.48M | -3.63M | -3.91M | -3.45M | -4.14M | -7.85M | -8.65M | -8.24M | -8.02M | -6.66M | -5.1M | -5.04M | -2.98M | -2.78M | -1.7M |
Net Income | -3.32M | -2.96M | -3.48M | -3.63M | -3.91M | -3.45M | -4.07M | -7.97M | -8.75M | -8.27M | -8.32M | -6.19M | -5.1M | -5.04M | -2.97M | -2.77M | -1.7M |
Selling & General & Admin | 994K | 802K | 874K | 840K | 896K | 751K | 986.8K | 3.17M | 2.16M | 2.75M | 2.89M | 3.34M | 2.58M | 2.64M | 1.4M | 1.45M | 542K |
Research & Development | 2.49M | 2.41M | 2.84M | 2.93M | 3.15M | 3.11M | 3.35M | 5.02M | 6.89M | 5.89M | 5.42M | 2.91M | 2.75M | 2.38M | 1.49M | 1.31M | 1.16M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.49M | 3.21M | 3.71M | 3.77M | 4.09M | 3.87M | 4.33M | 8.2M | 9.05M | 8.64M | 8.32M | 6.25M | 5.32M | 5.02M | 2.89M | 2.75M | 1.7M |
Interest Expense | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | 27K | 237K | 474.35K | n/a | 12.05K | 77.36K | 17.06K | 4.95K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.49M | 3.21M | 3.71M | 3.77M | 4.09M | 3.89M | 4.35M | 8.2M | 9.05M | 8.64M | 8.32M | 6.25M | 5.32M | 5.02M | 2.89M | 2.75M | 1.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | -16.75K | n/a | -54.82K | 34K | 21K | 10K | 237K | -544K | -28 | -50 | -42.13 | -25.8 | 72.48 |
Shares Outstanding (Basic) | 22.81M | 18.86M | 17.53M | 14.3M | 14.21M | 13.01M | 11.82M | 11.08M | 11.05M | 11.63M | 11.44M | 11.41M | 11.4M | 11.4M | 11.4M | 10.81M | 7.84M |
Shares Outstanding (Diluted) | 22.81M | 18.86M | 17.53M | 14.3M | 14.21M | 13.01M | 11.82M | 11.08M | 11.05M | 11.63M | 11.44M | 11.41M | 11.4M | 11.4M | 11.4M | 10.81M | 7.84M |
EPS (Basic) | -0.14 | -0.16 | -0.2 | -0.25 | -0.28 | -0.27 | -0.34 | -0.71 | -0.78 | -0.71 | -0.69 | -0.53 | -0.44 | -0.44 | -0.26 | -0.26 | -0.22 |
EPS (Diluted) | -0.14 | -0.16 | -0.2 | -0.25 | -0.28 | -0.27 | -0.34 | -0.71 | -0.78 | -0.71 | -0.69 | -0.53 | -0.44 | -0.44 | -0.26 | -0.26 | -0.22 |
EBITDA | -3.49M | -3.21M | -3.71M | -3.77M | -4.05M | -3.85M | -4.37M | -8.18M | -9.03M | -8.63M | -8.3M | -6.24M | -5.31M | -5.01M | -2.88M | -2.75M | -1.69M |
EBIT | -3.49M | -3.21M | -3.71M | -3.77M | -4.05M | -3.85M | -4.37M | -8.2M | -9.05M | -8.64M | -8.32M | -6.25M | -5.32M | -5.02M | -2.89M | -2.75M | -1.7M |
Depreciation & Amortization | 13.25K | 16.75K | 16.75K | 13.5K | 16.75K | 16.17K | 18.94K | 15.82K | 15.85K | 13.96K | 16.86K | 13.84K | 13.03K | 11.05K | 9.04K | 7.03K | 7K |